Clinical and immunological benefit of adjuvant therapy with thalidomide in the treatment of tuberculosis disease

AIDS. 2000 Aug 18;14(12):1859-61. doi: 10.1097/00002030-200008180-00026.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antitubercular Agents / therapeutic use*
  • CD4 Lymphocyte Count
  • Cytokines / biosynthesis*
  • Cytokines / drug effects
  • Female
  • HIV Seronegativity / immunology*
  • HIV Seropositivity / complications
  • HIV Seropositivity / immunology*
  • Humans
  • Male
  • Middle Aged
  • Thalidomide / therapeutic use*
  • Time Factors
  • Tuberculosis / drug therapy*
  • Viral Load

Substances

  • Antitubercular Agents
  • Cytokines
  • Thalidomide